Obstetrics & gynaecology

Study finds epilepsy drug to be safe during pregnancy

New research indicates that use of the epilepsy drug lamotrigine during pregnancy does not increase the risk of birth malformations or neurodevelopmental disorders. The British Journal of Clinical Pharmacology study provides ...

Neuroscience

Review: Levetiracetam best monotherapy for partial seizures

(HealthDay)—Levetiracetam performs better than carbamazepine and lamotrigine for individuals with partial seizures, according to a review and meta-analysis published online June 29 in the Cochrane Library.

Autism spectrum disorders

Exposure to antiepileptic drug in womb linked to autism risk

Children whose mothers take the antiepileptic drug sodium valproate while pregnant are at significantly increased risk of autism and other neurodevelopmental disorders, suggests a small study published online in the Journal ...

Medications

Perampanel for epilepsy: No proof of added benefit

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In an early benefit assessment according ...

Neuroscience

A more ethical way to compare epilepsy treatments

For the first time, a new research methodology recently approved by the Food and Drug Administration has been used to demonstrate that converting patients from one anti-epileptic drug to another - in this case, lamotrigine ...

page 1 from 2